Low-dose Radiotherapy Plus Chemotherapy With Gem-based Doublets and Stereotactic Radiotherapy for Advanced Pancreatic Cancer (ORCHESTRATE)
Low-dose Radiotherapy as a Chemo-potentiator of a Induction Chemotherapy Regimen With Gem-based Doublets and Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer
Sponsor: Azienda Ospedaliero-Universitaria di Modena
A NA clinical study on Pancreatic Cancer, this trial is ongoing. The trial is conducted by Azienda Ospedaliero-Universitaria di Modena and has accumulated 11 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
11 versions recorded-
Jan 2025 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Jan 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jan 2023 — Jul 2024 [monthly]
Recruiting NA
-
Feb 2021 — Jan 2023 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Recruiting NA
-
Feb 2019 — Jan 2021 [monthly]
Recruiting NA
-
Jun 2018 — Feb 2019 [monthly]
Recruiting NA
-
May 2018 — Jun 2018 [monthly]
Recruiting NA
-
Oct 2017 — May 2018 [monthly]
Recruiting NA
-
Jan 2017 — Oct 2017 [monthly]
Recruiting NA
First recorded
Jan 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Ospedaliero-Universitaria di Modena
For direct contact, visit the study record on ClinicalTrials.gov .